About Mineralys Therapeutics Inc - Company Information, Overview, History and Profile
What does Mineralys Therapeutics Inc do?
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
Mineralys Therapeutics Inc Management structure
All Gross Remunerations are in USD
Mr. Adam S. Levy
Chief Financial Officer, Principal Accounting Officer and Secretary